Deep learning and disease detection

07 April 2022

Marcel Gehrung, co-founder and CEO of rapidly growing Cambridge biotech company, Cyted, on revolutionising disease diagnostics and the challenges of building a business during a pandemic. 聽

Read More
DNA representation

New model predicts oesophageal cancer eight years early for half of all patients

07 September 2020

DNA from tissue biopsies taken from patients with Barrett鈥檚 oesophagus 鈥 a risk factor for oesophageal cancer 鈥 could show which patients are most likely to develop the disease eight years before diagnosis, suggests a study led by researchers at the 探花直播 of Cambridge and EMBL鈥檚 European Bioinformatics Institute (EMBL-EBI).

Read More
Professor Richard Gilbertson from the CRUK Cambridge Institute

Man on a mission to beat cancer

14 November 2016

Thirty years ago, Professor Richard聽Gilbertson聽pledged to implement a 15 per cent reduction in mortality from children鈥檚 brain cancer. This is the story of what happened next.

Interview: Lucy聽Jolin鈥

Read More

Pages